Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00QLH
|
||||
Former ID |
DNC013686
|
||||
Drug Name |
H-Dmt-Tic-D-Asp-N(Me)-Ph
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529630] | ||
Structure |
Download2D MOL |
||||
Formula |
C32H36N4O6
|
||||
Canonical SMILES |
CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(CC(=O)O)<br />C(=O)N(C)C4=CC=CC=C4)N)C)O
|
||||
InChI |
1S/C32H36N4O6/c1-19-13-24(37)14-20(2)25(19)16-26(33)31(41)36-18-22-10-8-7-9-21(22)15-28(36)30(40)34-27(17-29(38)39)32(42)35(3)23-11-5-4-6-12-23/h4-14,26-28,37H,15-18,33H2,1-3H3,(H,34,40)(H,38,39)/t26-,27+,28-/m0/s1
|
||||
InChIKey |
HEKBLCZSNQVJKZ-IARZGTGTSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Mu-type opioid receptor | Target Info | Inhibitor | [529630] | |
Delta-type opioid receptor | Target Info | Inhibitor | [529630] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Enkephalin releaseP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Enkephalin release | |||||
Opioid proenkephalin pathway | |||||
Opioid proopiomelanocortin pathway | |||||
Pathway Interaction Database | IL4-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.